Home
LEGN
LEGN News

Latest Legend Biotech Corporation (LEGN) News on July 26, 2024

MT Newswires

9 hours ago

Legend Biotech Reports Preliminary First-Half Financial Results

Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024

GlobeNewswire

12 hours ago

Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024

MT Newswires

11 days ago

TD Cowen Adjusts Legend Biotech Price Target to $67 From $71, Maintains Buy Rating

Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid

Zacks

11 days ago

Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid

Legend Biotech (LEGN) Surges 12.1%: Is This an Indication of Further Gains?

Zacks

11 days ago

Legend Biotech (LEGN) Surges 12.1%: Is This an Indication of Further Gains?

Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results

GlobeNewswire

16 days ago

Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results

MT Newswires

24 days ago

Legend Biotech Says Myeloma Drug Shows Positive Overall Survival Results

Legend Biotech Announces Positive Overall Survival Results of Landmark Phase 3 CARTITUDE-4 Trial in Multiple Myeloma

GlobeNewswire

24 days ago

Legend Biotech Announces Positive Overall Survival Results of Landmark Phase 3 CARTITUDE-4 Trial in Multiple Myeloma

Does Legend Biotech (LEGN) Have a Long Runway for Growth?

Insider Monkey

a month ago

Does Legend Biotech (LEGN) Have a Long Runway for Growth?

MT Newswires

a month ago

Truist Securities Initiates Legend Biotech With Buy Rating, $88 Price Target

MT Newswires

2 months ago

Legend Biotech Says Phase 2 Trial of Carvykti to Treat Multiple Myeloma Showed 'Deep, Durable' Responses

Legend Biotech Shares Data on the Earliest Use to Date of CARVYKTI® in the Treatment of Multiple Myeloma and Important Subgroup Analyses at ASCO and EHA

Business Wire

2 months ago

Legend Biotech Shares Data on the Earliest Use to Date of CARVYKTI® in the Treatment of Multiple Myeloma and Important Subgroup Analyses at ASCO and EHA

Legend Biotech to Participate in the Jefferies Global Healthcare Conference

Business Wire

2 months ago

Legend Biotech to Participate in the Jefferies Global Healthcare Conference

MT Newswires

2 months ago

HC Wainwright Adjusts Legend Biotech Price Target to $73 From $86, Maintains Buy Rating

MT Newswires

2 months ago

Deutsche Bank Starts Legend Biotech With Buy Rating

Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA

Business Wire

2 months ago

Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA

MT Newswires

2 months ago

MaxCyte Signs License Deal With Legend Biotech for Cell Therapy Program

MT Newswires

2 months ago

HC Wainwright Adjusts Price Target on Legend Biotech to $86 From $87, Keeps Buy Rating

MT Newswires

2 months ago

RBC Adjusts Price Target on Legend Biotech to $86 From $85 on Model Updates, Maintains Outperform Rating

GuruFocus.com

2 months ago

Legend Biotech Corp (LEGN) Q1 2024 Earnings Call Transcript Highlights: Soaring CARVYKTI Sales ...

Thomson Reuters StreetEvents

2 months ago

Q1 2024 Legend Biotech Corp Earnings Call

MT Newswires

2 months ago

Sector Update: Health Care Stocks Decline Pre-Bell Monday

MT Newswires

2 months ago

Sector Update: Health Care

MT Newswires

2 months ago

Legend Biotech Q1 Net Loss Narrows as Revenue Rises; Shares Rise Pre-Bell

Legend Biotech Reports First Quarter 2024 Results and Recent Highlights

Business Wire

2 months ago

Legend Biotech Reports First Quarter 2024 Results and Recent Highlights

Should You Buy Legend Biotech (LEGN) Ahead of Earnings?

Zacks

3 months ago

Should You Buy Legend Biotech (LEGN) Ahead of Earnings?

MT Newswires

3 months ago

Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer

$CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma$

Business Wire

3 months ago

CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma

Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results

Business Wire

3 months ago

Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results

FDA Expands J&J's (JNJ) Carvykti Label in Multiple Myeloma

Zacks

4 months ago

FDA Expands J&J's (JNJ) Carvykti Label in Multiple Myeloma

Why Legend Biotech (LEGN) Stock Might be a Great Pick

Zacks

4 months ago

Why Legend Biotech (LEGN) Stock Might be a Great Pick

Reuters

4 months ago

U.S. FDA approves expanded use of J&J's cancer cell therapy

Legend Biotech’s CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma

Business Wire

4 months ago

Legend Biotech’s CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma

Should You Continue to Hold Legend Biotech Corporation (LEGN)?

Insider Monkey

4 months ago

Should You Continue to Hold Legend Biotech Corporation (LEGN)?

Management’s Conservative Guidance Led Legend Biotech Corporation (LEGN) to Decline in Q4

Insider Monkey

4 months ago

Management’s Conservative Guidance Led Legend Biotech Corporation (LEGN) to Decline in Q4

Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report

Business Wire

4 months ago

Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report

30 Biggest Biotechnology Companies in the World

Insider Monkey

4 months ago

30 Biggest Biotechnology Companies in the World

$CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma$

Business Wire

4 months ago

CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma

Legend Biotech Corporation (NASDAQ:LEGN) Q4 2023 Earnings Call Transcript

Insider Monkey

4 months ago

Legend Biotech Corporation (NASDAQ:LEGN) Q4 2023 Earnings Call Transcript

The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys

Zacks

5 months ago

The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys

Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights

Business Wire

5 months ago

Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights

5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024

Zacks

5 months ago

5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024

An Intrinsic Calculation For Legend Biotech Corporation (NASDAQ:LEGN) Suggests It's 47% Undervalued

Simply Wall St.

5 months ago

An Intrinsic Calculation For Legend Biotech Corporation (NASDAQ:LEGN) Suggests It's 47% Undervalued

$Legend Biotech Announces Positive CHMP Opinion for CARVYKTI® (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy$

Business Wire

5 months ago

Legend Biotech Announces Positive CHMP Opinion for CARVYKTI® (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy

Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2023 Results

Business Wire

5 months ago

Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2023 Results

Matthews Emerging Markets Small Companies Fund Bolsters Position in CarTrade Tech Ltd

GuruFocus.com

6 months ago

Matthews Emerging Markets Small Companies Fund Bolsters Position in CarTrade Tech Ltd

Carlisle Receives First-Ever LEED Platinum v4 Certification in North America

Business Wire

6 months ago

Carlisle Receives First-Ever LEED Platinum v4 Certification in North America

Analysts Estimate StepStone Group Inc. (STEP) to Report a Decline in Earnings: What to Look Out for

Zacks

6 months ago

Analysts Estimate StepStone Group Inc. (STEP) to Report a Decline in Earnings: What to Look Out for

Equity LifeStyle Properties, Inc. (NYSE:ELS) Q4 2023 Earnings Call Transcript

Insider Monkey

6 months ago

Equity LifeStyle Properties, Inc. (NYSE:ELS) Q4 2023 Earnings Call Transcript

South China Morning Post

6 months ago

Ant Group inks strategic partnership with Shanghai to help the city's AI ambitions

South China Morning Post

6 months ago

Alibaba, Tencent gain as Hong Kong stocks snap 2-day slump on China data while markets eye Fed rate cut in May

Avery Dennison (AVY) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

6 months ago

Avery Dennison (AVY) Reports Q4 Earnings: What Key Metrics Have to Say

Reuters

6 months ago

UPDATE 1-Southwest prepared to wait for delayed Boeing MAX 7s, executive says

Southwest prepared to wait for delayed Boeing MAX 7s, executive says

Reuters

6 months ago

Southwest prepared to wait for delayed Boeing MAX 7s, executive says

Global Electric Commercial Vehicle Battery Market Report 2023-2030: Demand, Regional Share, Technology Roadmap, Cost Dynamics, Price Forecasts, and Profiles of Major Battery Cell Suppliers

GlobeNewswire

6 months ago

Global Electric Commercial Vehicle Battery Market Report 2023-2030: Demand, Regional Share, Technology Roadmap, Cost Dynamics, Price Forecasts, and Profiles of Major Battery Cell Suppliers

Zacks Industry Outlook Highlights Publicis Groupe, Omnicom Group and WPP

Zacks

6 months ago

Zacks Industry Outlook Highlights Publicis Groupe, Omnicom Group and WPP

Alabama’s Shelby County Commission to Deploy NICE’s Market Leading Digital Evidence Management Platform to Transform Criminal Justice

Business Wire

6 months ago

Alabama’s Shelby County Commission to Deploy NICE’s Market Leading Digital Evidence Management Platform to Transform Criminal Justice

What Is Owens Corning's (NYSE:OC) Share Price Doing?

Simply Wall St.

6 months ago

What Is Owens Corning's (NYSE:OC) Share Price Doing?

Best Buy's (NYSE:BBY) earnings trajectory could turn positive as the stock climbs 6.0% this past week

Simply Wall St.

6 months ago

Best Buy's (NYSE:BBY) earnings trajectory could turn positive as the stock climbs 6.0% this past week

Is Live Nation Entertainment, Inc. (NYSE:LYV) Potentially Undervalued?

Simply Wall St.

6 months ago

Is Live Nation Entertainment, Inc. (NYSE:LYV) Potentially Undervalued?

DraftKings to Release Fourth Quarter and Full Year 2023 Results on February 15, 2024 and Host Conference Call on February 16, 2024

GlobeNewswire

6 months ago

DraftKings to Release Fourth Quarter and Full Year 2023 Results on February 15, 2024 and Host Conference Call on February 16, 2024

Warren Buffett Bolsters Holdings in Liberty SiriusXM Group

GuruFocus.com

6 months ago

Warren Buffett Bolsters Holdings in Liberty SiriusXM Group

DraftKings, Barstool deal would 'make a lot of sense': Analyst

Yahoo Finance Video

6 months ago

DraftKings, Barstool deal would 'make a lot of sense': Analyst

Jabil Declares Quarterly Dividend

Business Wire

6 months ago

Jabil Declares Quarterly Dividend

Reuters

6 months ago

CORRECTED-UPDATE 1-Xcel Energy posts higher Q4 profit on lower operating expenses

New solutions emerge to better integrate renewables into the grid, Xcel, Eversource and others say

Utility Dive

6 months ago

New solutions emerge to better integrate renewables into the grid, Xcel, Eversource and others say

Packaging Corp of America (PKG) Navigates Market Challenges with Resilient 2023 Performance

GuruFocus.com

6 months ago

Packaging Corp of America (PKG) Navigates Market Challenges with Resilient 2023 Performance

3 Reasons Roku Stock Could Crush the Market for the Next Decade

Motley Fool

6 months ago

3 Reasons Roku Stock Could Crush the Market for the Next Decade

Fox Business

6 months ago

Knott's Berry Farm, 100-year-old jam and cookie brand, is discontinued in stores

Samsara Sues to Stop Patent Infringement, False Advertising by Motive

Business Wire

6 months ago

Samsara Sues to Stop Patent Infringement, False Advertising by Motive

Q3 Earnings Highs And Lows: Home Depot (NYSE:HD) Vs The Rest Of The Home Furnishing and Improvement Retail Stocks

StockStory

6 months ago

Q3 Earnings Highs And Lows: Home Depot (NYSE:HD) Vs The Rest Of The Home Furnishing and Improvement Retail Stocks

Barrick (GOLD) Achieves Production Targets in Tanzanian Mines

Zacks

6 months ago

Barrick (GOLD) Achieves Production Targets in Tanzanian Mines

Why Darden Restaurants (DRI) is a Top Value Stock for the Long-Term

Zacks

6 months ago

Why Darden Restaurants (DRI) is a Top Value Stock for the Long-Term

Reuters

6 months ago

UPDATE 6-US FDA seeks 'boxed warning' for CAR-T cancer therapies

Reuters

6 months ago

US FDA requires 'boxed warning' for CAR-T cancer therapies

Camden Property Trust Announces Tax Characteristics of 2023 Distributions

Business Wire

6 months ago

Camden Property Trust Announces Tax Characteristics of 2023 Distributions

Vistra Issues Reminder Regarding Expiration of Warrants

PR Newswire

6 months ago

Vistra Issues Reminder Regarding Expiration of Warrants

Should You Expect Strong Financial Growth For Legend Biotech Corporation (LEGN)?

Insider Monkey

6 months ago

Should You Expect Strong Financial Growth For Legend Biotech Corporation (LEGN)?

BeiGene, Ltd. (NASDAQ:BGNE): Is Breakeven Near?

Simply Wall St.

6 months ago

BeiGene, Ltd. (NASDAQ:BGNE): Is Breakeven Near?

Reuters

6 months ago

UPDATE 1-Huntington Bancshares profit falls on FDIC charge, interest income weakness

Huntington (HBAN) Q4 Earnings Beat Estimates, Revenues Dip Y/Y

Zacks

6 months ago

Huntington (HBAN) Q4 Earnings Beat Estimates, Revenues Dip Y/Y

Royalty Pharma Announces Dividend Increase

GlobeNewswire

6 months ago

Royalty Pharma Announces Dividend Increase

3 No-Brainer Stocks to Buy Right Now for Less than $50

Motley Fool

6 months ago

3 No-Brainer Stocks to Buy Right Now for Less than $50

Manufacturing Marvels: 3 Industrial Stocks Set for Success

InvestorPlace

6 months ago

Manufacturing Marvels: 3 Industrial Stocks Set for Success

IHG Hotels & Resorts Strengthens Leading Position in the Luxury & Lifestyle Segment

PR Newswire

6 months ago

IHG Hotels & Resorts Strengthens Leading Position in the Luxury & Lifestyle Segment

Investors in IDEX (NYSE:IEX) have seen decent returns of 59% over the past five years

Simply Wall St.

6 months ago

Investors in IDEX (NYSE:IEX) have seen decent returns of 59% over the past five years

Nordson Corporation Elects Christopher Mapes to its Board of Directors

Business Wire

6 months ago

Nordson Corporation Elects Christopher Mapes to its Board of Directors

BioMarin Pharmaceutical (BMRN) is a Top-Ranked Growth Stock: Should You Buy?

Zacks

6 months ago

BioMarin Pharmaceutical (BMRN) is a Top-Ranked Growth Stock: Should You Buy?

3 Super-Safe High-Yield Dividend Stocks You Can Buy Right Now

Motley Fool

6 months ago

3 Super-Safe High-Yield Dividend Stocks You Can Buy Right Now

Deutsche Bank Refis South Florida Mixed-Use Asset With $133M Loan

Commercial Observer

6 months ago

Deutsche Bank Refis South Florida Mixed-Use Asset With $133M Loan

TIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics License Application Accepted for Priority Review by U.S. Food and Drug Administration for Patients with Recurrent or Metastatic Cervical Cancer

GlobeNewswire

7 months ago

TIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics License Application Accepted for Priority Review by U.S. Food and Drug Administration for Patients with Recurrent or Metastatic Cervical Cancer

Warren Buffett's Berkshire Bolsters Holdings in Liberty SiriusXM Group Acquisition

GuruFocus.com

7 months ago

Warren Buffett's Berkshire Bolsters Holdings in Liberty SiriusXM Group Acquisition

3 Top Biotech Stocks Worth Adding to Your Portfolio in 2024

Zacks

7 months ago

3 Top Biotech Stocks Worth Adding to Your Portfolio in 2024

FriendliAI Unveils Serverless Endpoints for Widespread, Affordable Access to Open-source Generative AI Models

PR Newswire

7 months ago

FriendliAI Unveils Serverless Endpoints for Widespread, Affordable Access to Open-source Generative AI Models

Legend Biotech Announces Closing of License Transaction for Certain CAR-T Therapies Targeting DLL3

Business Wire

7 months ago

Legend Biotech Announces Closing of License Transaction for Certain CAR-T Therapies Targeting DLL3

Industrial Precision Unit Aids Nordson (NDSN) Amid Cost Woes

Zacks

7 months ago

Industrial Precision Unit Aids Nordson (NDSN) Amid Cost Woes

Legend Biotech to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire

7 months ago

Legend Biotech to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

13 High Growth Healthcare Stocks to Buy

Insider Monkey

7 months ago

13 High Growth Healthcare Stocks to Buy

Should You Hold Vistra Corp. (VST) for the Long-Term?

Insider Monkey

7 months ago

Should You Hold Vistra Corp. (VST) for the Long-Term?

Host Hotels & Resorts Announces Fourth Quarter 2023 Earnings Call to be Held on February 22, 2024

GlobeNewswire

7 months ago

Host Hotels & Resorts Announces Fourth Quarter 2023 Earnings Call to be Held on February 22, 2024

Share on Social Networks: